Abstract
This initiative is based on research that has been funded by the Consejeria de Educacion, Cultura y Deportes, JCCM, Spain, project ´ CCM17-PIC-036 (SBPLY/17/180501/000185)
Highlights
Ongoing research focuses on vaccines targeting SARS-CoV-2 for the prevention and control of COVID-19
Boosting the immune response to glycan α-Gal with a broader and not restricted to pathogen-specific immunity may contribute to the control of COVID-19 and to other pathogens that negatively affect the individual response to SARS-CoV-2
Despite the advances and potential impact that these vaccines represent for the prevention and control of COVID-19, interventions boosting the immune response with a broader and not pathogen-specific immunity may contribute to the control of COVID-19 and to potential reinfections by SARS-CoV-2-related genetic variants or other pathogens that negatively affect the individual response to SARS-CoV-2
Summary
Ongoing research focuses on vaccines targeting SARS-CoV-2 for the prevention and control of COVID-19. Boosting the immune response to glycan α-Gal with a broader and not restricted to pathogen-specific immunity may contribute to the control of COVID-19 and to other pathogens that negatively affect the individual response to SARS-CoV-2.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
